추가 설명:
AdimFlu-S, developed by Adimmune Corporation, is an inactivated trivalent seasonal influenza vaccine containing WHO-recommended strains for annual protection against circulating influenza. It is indicated for active immunization in children aged 3 and older and adults, protecting against disease from two influenza A strains and one influenza B strain in the formulation. Supplied as a sterile injectable suspension, administered intramuscularly.
평가 & 댓글 남기기